2022
DOI: 10.2340/actadv.v102.2293
|View full text |Cite
|
Sign up to set email alerts
|

Activation of NLRP3 Inflammasome in the Skin of Patients with Systemic and Cutaneous Lupus Erythematosus

Abstract: NLRP3 inflammasome is suggested to contribute to the complex pathogenesis of systemic lupus erythematosus, but its role in cutaneous lupus erythematosus has not been addressed. This study investigated the expression of NLRP3 inflammasome components and levels of type I interferons in the skin of 20 patients with cutaneous lupus erythematosus. Expression of NLRP1/3, adaptor protein ASC (apoptosis-associated speck-like protein), caspase-1, interleukin-1β, interferon-α, myxovirus resistance protein I and interfer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 42 publications
1
8
0
Order By: Relevance
“…OAS3 is a member of the 2’-5’-oligoadenylate synthetase family and is involved in immune responses, which could restrict the replication of certain types of viruses ( 62 , 63 ). Interferon-induced protein with tetratricopeptide repeats (IFIT) 1 is a member of the IFIT family and plays an important role in antiviral processes, and research has revealed that IFIT1 is involved in the development of systemic lupus erythematosus (SLE) ( 64 , 65 ). Interferon-induced protein 44-like is an interferon-induced gene overexpressed in patients with SLE that might be a drug target of SLE ( 66 ).…”
Section: Discussionmentioning
confidence: 99%
“…OAS3 is a member of the 2’-5’-oligoadenylate synthetase family and is involved in immune responses, which could restrict the replication of certain types of viruses ( 62 , 63 ). Interferon-induced protein with tetratricopeptide repeats (IFIT) 1 is a member of the IFIT family and plays an important role in antiviral processes, and research has revealed that IFIT1 is involved in the development of systemic lupus erythematosus (SLE) ( 64 , 65 ). Interferon-induced protein 44-like is an interferon-induced gene overexpressed in patients with SLE that might be a drug target of SLE ( 66 ).…”
Section: Discussionmentioning
confidence: 99%
“…When compared to non-atherosclerotic arteries, atherosclerotic vessels have considerably higher levels of IL1B expression, which concurrently promotes the development of AS plaque. 21 Additionally, IL1B expression was found to be elevated in SLE patients, 22 which promotes the production of IFN-γ by CD4+ T cells mainly through an autocrine manner, 23 while serum IFN-γ is a potential biomarker of SLE disease activity. 24 The studies mentioned above are consistent with the findings of this research and provide more evidence for the viability of AQP9, CCR1, CD83, CXCL1, FCGR2A, IL1RN, IL1B, and TNF as targets for the diagnosis and treatment of SLE and AS.…”
Section: Discussionmentioning
confidence: 99%
“…Canonical inflammasomes are involved in the pathogenesis of SLE and lupusrelated diseases such as lupus nephritis and are regarded as potential targets for SLE treatment [82][83][84][85][86]. Recent studies have also reported the regulatory role of non-canonical inflammasomes in SLE pathogenesis.…”
Section: Systemic Lupus Erythematosus (Sle)mentioning
confidence: 99%